Healthcare COVID-19 treatment: Glenmark cuts Favipiravir price to Rs 75 per tab from Rs 103 per tab earlier Updated : July 13, 2020 12:29 PM IST Glenmark sells the drug, used in the treatment of COVID-19, under the brand name FabiFlu. The oral antiviral favipiravir has been approved under emergency use authorization for the treatment of mild to moderate COVID-19 patients. Subscribe to Moneycontrol PRO at just Rs.33/- per month for the first year. Use code SUPERPRO. Limited period offer. Available on Web and Android.